FDA. Cautions in using rapid tests for detecting influenza A viruses. Nov 14, 2005 [Full text]
WHO. Manual on animal influenza diagnosis and surveillance [Full text]
WHO. Recommended laboratory tests to identify influenza A/H5 in specimens from patients with influenza-like illness [Full text]
CDC. Interim guidance for influenza diagnostic testing during the 2004-05 influenza season. Nov 2004 [Full text]
CDC. Lab diagnosis. [Web page]
CDC. National Respiratory and Enteric Virus Surveillance System (NREVSS) [Web page]
CDC. New laboratory assay for diagnostic testing of avian influenza A0H5 (Asian lineage). MMWR 2006 Feb 3;55(Early release):1 [Full text]
Alford RH, Kasel JA, Gerone PJ, et al. Human influenza resulting from aerosol inhalation. Proc Soc Exp Biol Med 1966 Jul;122(3):800-4
Bean B, Moore BM, Sterner B, Peterson LR, Gerding DN, Balfour HH Jr. Survival of influenza viruses on environmental surfaces. J Infect Dis 1982 Jul;146(1):47-51 [Abstract]
Belshe RB. The origins of pandemic influenzalessons form the 1918 virus. N Engl J Med 2005 Nov 24;353(21):2209-11 [Full text]
Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in healthcare settings. Clin Infect Dis 2003 (Oct 15);37(8):1094-1101 [Full text]
Alexander DJ. Should we change the definition of avian influenza for eradication purposes? Avian Dis 2003;47(3 Suppl):976-81 [Abstract]
Acambis. Acambis enters flu vaccine arena with launch of flu vaccine development programme. Aug 4, 2005 [Full text]
ASTHO. Nature's terrorist atack: pandemic influenza. Preparedness planning for state health officials [Full text]
ASTHO. Nature's terrorist attack: pandemic influenza. Preparedness planning for state health officials [Full text]
Australian Government Department of Health and Ageing. Influenza laboratory case definition [Full text]
Balicer RD, Huerta M, Davidovitch N, et al. Cost-benefit of stockpiling drugs for influenza pandemic. Emerg Infect Dis 2005 Aug;11(8):1280-2 [Full text]
Barry JM. 1918 revisited: lessons and suggestions for further inquiry. In: The threat of pandemic influenza: are we ready? Institute of Medicine. Nov 16, 2004 [Full text]
Beveridge WI. Influenza: the last great plague. New York, NY: Prodist, 1978
Butler D. Alarms rising over bird flu mutations. Nature 2006 Jan 19;439:248-9 [Full text]
Call SA, Vollenweider MA, Hornung CA, Simel DL, McKinney WP. Does this patient have influenza? JAMA 2005 Feb 23;293(8):987-97 [Abstract]
Capua I, Alexander DJ. Avian influenza: recent developments. Avian Pathol 2004 Aug;33(4):393-404 [Abstract]
CDC. CDC recommends against the use of amantadine and rimantadine for the treatment or prophylaxis of influenza in the United States during the 200506 influenza season. CDC Health Alert. Jan 14, 2006 [Full text]
CDC/HICPAC. Guideline for isolation precautions in hospitals, 1994 [Full text]
CDC/HICPAC. Guidelines for preventing healthcare associated pneumonia, 2003 [Full text]
CDC. Interim recommendations for infection control in health-care facilities caring for patients with known or suspected avian influenza [Full text]
CDC. Interim CDC-NIH recommendation for raising the biosafety level for laboratory work involving noncontemporary human influenza (H2N2) viruses [Full text]
CDC. Respiratory hygiene/cough etiquette in healthcare settings [Web page]
CDC. Select Agent Program [Web page]
CDC. Update on influenza A(H5N1) and SARS: Interim recommendations for enhanced U.S. surveillance, testing, and infection controls [Full text]
Chan M CW, Cheung CY, Chui WH, et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Resp Res 2005 Nov 11;6(1):135 [Full text]
Coiras MT, Perez-Brena P, Garcia ML, et al. Simultaneous detection of influenza A, B, and C viruses, respiratory syncytial virus, and adenoviruses in clinical samples by multiplex reverse transcription nested-PCR assay. J Med Virol 2003 Jan;69(1):132-44 [Abstract]
Crawford PC, Dubovi EJ, Castleman WL, et al. Transmission of equine influenza virus to dogs. Science 2005 Oct 21;310(5747):482-5 [Abstract]
CSTE. Influenza preparedness state plans [Web page]
Cunha BA. Influenza: historical aspects of epidemics and pandemics. Infect Dis Clin North Am 2004 Mar;18:141-55 [Abstract]
Cyranoski D. Bird flu spreads among Java pigs. (News) Nature 2005 May 26;435(7041):390-1 [Full text]
DeJong MD, Thanh TT, Khanh TH, et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 2005 Dec 22;353:2667-72 [Full text]
Dowdle WR. Influenza pandemic periodicity, virus recycling, and the art of risk assessment. Emerg Infect Dis 2006 Jan;12(1):34-9 [Full text]
Epstein SL. Control of influenza virus infection by immunity to conserved viral features. Expert Rev Anti Infect Ther 2003 Dec;1(4):627-38 [Abstract]
Fauci AS. Pandemic influenza threat and preparedness. Emerg Infect Dis 2006 Jan;12(1):73-6 [Full text]
Fedson DS. Pandemic influenza and the global vaccine supply. Clin Infect Dis 2003 Jun 15;36(12):1552-61 [Full text]
Fedson DS. Vaccination for pandemic influenza; a six point agenda for interpandemic years. Pediatr Infect Dis J 2004 Jan;23(1 Suppl):S74-7 [Abstract]
Fedson D. Pandemic influenza vaccine: obstacles and opportunities. In: The threat of pandemic influenza: are we ready? Institute of Medicine. Nov 16, 2004 [Full text of book]
Fouchier RAM, Munster V, Wallensten A, et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls J Virol 2005 Apr;79(5):2814-22 [Abstract]
Gani R, Hughes H, Fleming D, et al. Potential impact of antiviral drug use during influenza pandemic. Emerg Infect Dis 2005 Sep;11(9):1355-62 [Full text]
Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev 1996;18(1):64-76
Gubareva LV, Matrosovich MN, Brenner MK, et al. Evidence of zanamivir resistance in an immunocompromised child infected with influenza B virus. J Infect Dis 1998;178:1257-62
Hampson AW. Surveillance for pandemic influenza. J Infect Dis 1997 Aug;176(Suppl 1):S8-13 [Abstract]
Hayden FG. Perspectives on antiviral use during pandemic influenza. In: The threat of pandemic influenza: are we ready? Institute of Medicine. Nov 16, 2004 [Full text of book]
Hayden FG, Cote KM, Douglas RG Jr. Plaque inhibition assay for drug susceptibility testing of influenza viruses. Antimicrob Agents Chemother 1980 May;17(5):865-70 [Full text]
Hayden FG, Palese P. Influenza virus. In: Richman DD, Whitley RJ, Hayden FG, eds. Clinical virology. Ed. 2. Washington, DC: ASM Press, 2002
Henle W, Henle G, Stokes J, et al. Experimental exposure of human subjects to viruses of influenza. J Immunol 1946;52:145-65
Herrmann B, Larsson C, Zweygberg BW. Simultaneous detection and typing of influenza viruses A and B by a nested reverse transcription-PCR: comparison to virus isolation and antigen detection by immunofluorescence and optical immunoassay (FLU OIA). J Clin Microbiol 2001 Jan;39(1):134-8 [Full text]
HHS. Influenza pandemics: how they start, how they spread, and their potential impact. National Vaccine Program Office [Web page]
HHS. PandemicFlu.gov [Home page]
HHS. Pandemic influenza plan. Released Nov 2, 2005 [Links to overview and full text]
Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918-20 "Spanish" influenza pandemic. Bull His Med 2002;76:105-15 [Abstract]
Kaye D, Pringle CR. Avian influenza viruses and their implications for human health. Clin Infect Dis 2005 Jan 1;40(1):108-12 [Abstract]
Keawcharoen J, Oraveerakul K, Kuiken T, et al. Avian influenza H5N1 in tigers and leopards. Emerg Infect Dis 2004 Dec;10(12) [Full text]
Kessler N, Ferraris O, Palmer K, et al. Use of the DNA flow-thru chip, a three-dimensional biochip, for typing and subtyping of influenza viruses. J Clin Microbiol 2004 May;42(5):2173-85[Full text]
Kilbourne ED. Influenza pandemics of the 20th century. Emerg Infect Dis 2006 Jan;12(1):9-14 [Full text]
Kobasa D, Takada A, Shinya K, et al. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 2004 Oct 7;431(7009);703-7 [Abstract]
Le QM, Kiso M, Someya K, et al. Avian flu: isolation of drug-resistant H5N1 virus. Nature 2005 Oct 20;437(7062):1108 [Abstract]
Lee, VJ, Phua, KH, Chen MI, et al. Economics of neuraminidase inhibitor stockpiling for pandemic influenza, Singapore. Emerg Infect Dis 2006 Jan;12(1) [Full text]
Li KS, Guan Y, Wang J, et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 2004 Jul 8;430:209-13 [Abstract]
Lipotov AS, Webby RJ, Govorkova EA, et al. Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model. J Infect Dis 2005 Apr 15;191:1216-20 [Abstract]
Loosli CG, Lemon HM, Robertson OH, et al. Experimental airborne influenza infection. I. Influence of humidity on survival of virus in air. Proc Soc Exp Biol 1943; 53:205-6
Luke CJ, Subbarao K. Vaccines for pandemic influenza. Emerg Infect Dis 2006 Jan;12(1):66-72 [Full text]
McKimm-Breschkin J, Trivedi T, et al. Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother. 2003 Jul;47(7):2264-72 [Full text]
Medema JK, Zoellner, YF, Ryan J, et al. Modeling pandemic preparedness scenarios: health economic implications of enhanced pandemic vaccine supply. Virus Res 2004 Jul;103(1-2):9-15 [Abstract]
Monto AS. The threat of an avian influenza pandemic. N Engl J Med 2005 Jan 27;352(4):323-4 [Full text]
Monto AS. Vaccines and antiviral drugs in pandemic preparedness. Emerg Infect Dis 2006 Jan;12(1):55-60 [Full text]
Moscona A. Neuraminidase inhibitors for influenza. New Engl J Med 2005 Sept 29;353:13:1363-73
Moser MR, Bender TR, Margolis HS, et al. An outbreak of influenza abroad a commercial airliner. Am J Epidemiol 1979;110(1):1-6
Newton DW, Mellen CF, Baxter BD, et al. Practical and sensitive screening strategy for detection of influenza virus. J Clin Microbiol 2002 Nov;40(11):4353-6 [Full text]
NIAID. Significant dates in influenza history [Web page]
NIAID. NIAID announces contracts to develop vaccine against H5N1 avian influenza. May 2004 [Press release]
NIAID. Focus on the flu [Web page]
NSC (National Security Council. National Strategy for pandemic influenza: implementation plan. Released May 3, 2006 [Full text]
OIE (World Organization for Animal Health). Avian influenza. Chap 2.7.12. In: Manual of diagnostic tests and vaccines for terrestrial animals. May 2005 [Full text]
Olsen SJ, Ungchusak K, Sovann L, et al. Family clustering of avian influenza A (H5N1). [Letter] Emerg Infect Dis 2005 Nov;11(11):1799-1800 [Full text]
Osterholm MT. Avian flu: addressing the global threat. Testimony before the House Committee on International Relations. Dec 7, 2005 [Full text]
Osterholm MT. A weapon the world needs. Nature 2005 May 26;435(7041):417-8 [Full text]
Osterholm MT. Preparing for the next pandemic. (Perspective) N Engl J Med 2005 May 5;352(18):1839-42 [Full text]
Osterholm MT. Preparing for the next pandemic. Foreign Aff 2005 Jul/Aug;84(4) [Full text]
Oxford JS. Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology. Rev Med Virol 2000 Mar-Apr;10(2):119-33 [Abstract]
Pachucki CT, Khurshid MA, Nawrocki J. Utility of reverse transcriptase PCR for rapid diagnosis of influenza a virus infection and detection of amantadine-resistant influenza a virus isolates. J Clin Microbiol. 2004 Jun;42(6):2796-8 [Full text]
Palese P. Making better influenza virus vaccines? Emerg Infect Dis 2006 Jan;12(1):61-5 [Full text]
Perdue ML. Molecular diagnostics in an insecure world. Avian Dis 2003;47(3 Suppl):1063-8 [Abstract]
Reid AH, Taubenberger JK, Fanning TG. The 1918 Spanish influenza: integrating history and biology. Microbes Infect 2001 Jan:3(1):81-7 [Abstract]
Riley RL. Airborne infection. Am J Med 1974; 57:46675
Rowe T, Abernathy RA, Hu-Primmer J, et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 1999 Apr;37(4):937-43 [Full text]
Schulman JL. Experimental transmission of influenza virus infection in mice. IV. Relationship between transmissibility of different strains of virus and recovery of airborne virus in the environment of infector mice. J Exp Med 1967;125:479-88
Simonsen L, Olson DR, Viboud C, et al. Pandemic influenza and mortality: past evidence and projections for the future. In: The threat of pandemic influenza: are we ready? Institute of Medicine. Nov 16, 2004 [Full text of book]
Stephenson I, Bugarini R, Nicholson KG, et al. Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/duck/Singapore/97 (H5N3) vaccine: a potential priming strategy. J Infect Dis 2005 Apr 15;191:1210-5 [Abstract]
Stephenson I, Nicholson KG, Wood JM, et al. Confronting the avian influenza threat: vaccine development for a potential pandemic. Lancet Infect Dis 2004 Aug;4(8):499-509 [Abstract]
Stohr K. Avian influenza and pandemics: research needs and opportunities. N Engl J Med 2005 Jan 27;352(4): 405-7. Available ahead of print online at [Full text]
Taubenberger JK, Reid AH, Lourens RM, et al. Characterization of the 1918 influenza virus polymerase genes. (Letter) Nature 2005;437(7060):889-93 [Full text]
Taunberger JK, Morens DM. 1918 influenza: the mother of all pandemics. Emerg Infect Dis 2006 Jan;12(1):15-22 [Full text]
Thomas PG, Keating R, Hulse-Post DJ, et al. Cell-mediated protection in influenza infection. Emerg Infect Dis 2006 Jan;12(1):48-54 [Full text]
Treanor JJ. Influenza Virus. In: Mandell GL, Douglas RG, Bennett JE, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Ed 6. Philadelphia: Elsevier, 2005
Tumpey TM, Basler CF, Aguilar PV, et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 2005 Oct 7;310(5745):77-80 [Abstract]
Tumpey TM, Garcia-Sastre A, Mikulasova A, et al. Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci 2002 Oct 15;99(21):13849-54 [Abstract]
Ungchusak K, Auewarakul P, Dowell SF, et al. Probable person-to-person transmission of avian influenza (H5N1). N Engl J Med 2005 Jan 27;352(4):323-4 [Full text]
USDA/APHIS. Agricultural Bioterrorism Protection Act of 2002: Possession, use, and transfer of biological agents and toxins. Final Rule 7 CFR Part 331 and 9 CFR Part 121. Fed Reg 2005 Mar 18;70(52):13242-92 [Full text]
USDA/APHIS. Questions and answers on the Agricultural Bioterrorism Protection Act of 2002: Possession, use, and transfer of select agents and toxins. APHIS factsheet. May 2005 [Full text]
Voyles BA. Orthomyxoviruses. In: The biology of viruses. Ed 2. New York, NY: McGraw-Hill, 2002:147
Wallace LA, McAulay KA, Douglas JD, et al. Influenza diagnosis: from dark isolation into the molecular light. West of Scotland Respiratory Virus Study Group. J Infect 1999 Nov;39(3):221-6 [Abstract]
Webby RJ, Perez DR, Coleman JS, et al. Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. Lancet 2004 Apr 3;363(9415):1099-103 [Abstract]
Webster RG. Predictions for future human influenza pandemics. J Infect Dis 1997 Aug;176(Suppl 1):S14-19 [Full text]
Webster RG, Peiris M, Chen H, et al. H5N1 outbreaks and enzootic influenza. Emerg Infect Dis 2006 Jan;12(1):3-8 [Full text]
Weinberg A. Evaluation of three influenza a and B rapid antigen detection kitsupdate. Clin Diagn Lab Immunol 2005 Aug;12(8):1010 [Listing with link]
Wetherall NT, Trivedi T, Zeller J, et al. Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network. J Clin Microbiol 2003 Feb;41(2):742-50 [Full text]
WHO. Avian influenza: assessing the pandemic threat [Full text]
WHO. Avian influenza fact sheet [Web page]
WHO. Avian influenza, including influenza A (H5N1), in humans; WHO interim infection control guideline for health care facilities [Full text]
WHO. Avian influenza: situation (birds) in Nigeria. Feb 8, 2006 [Full text]
WHO. Avian influenza: situation updates [Full text]
WHO. Avian influenza: update: implications of H5N1 infections in pigs in China. Aug 25, 2004 [Web page]
WHO. Clarification: Use of masks by health-care workers in pandemic settings [Full text]
WHO. Consultation on priority public health interventions before and during an influenza pandemic [Full text]
WHO. Cumulative number of confirmed human cases of avian influenza A(H5N1) [Web pageopen most recent report available]
WHO. Current WHO phase of pandemic alert [Web page]
WHO. Development of a vaccine effective against avian influenza H5N1 infection in humans: update 4. Jan 20, 2004 [Web page]
WHO. Influenza pandemic preparedness and response. Jan 20, 2005 [Full text]
WHO. Inter-country consultation: influenza A/H5N1 in humans in Asia. May 6-7, 2005; Manila, The Phillipines. [Full text]
WHO. WHO checklist for influenza pandemic preparedness planning. 2005 [Full text]
WHO. WHO global influenza preparedness plan: the role of WHO and recommendations for national measures before and during pandemics. Apr 2005 [Full text]
WHO Global Influenza Program Surveillance Network. Evolution of H5N1 avian influenza viruses in Asia. Emerg Infect Dis 2005 October 11(10):1515-21[Full text]
WHO Writing Committee of WHO Consultation on Human Influenza A/H5. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005 Sep 29;353(13):1374-85 [Full text]
WHO Writing Group. Nonpharmaceutical interventions for pandemic influenza, international measures. Emerg Infect Dis 2006 Jan;12(1):81-7 [Full text]
WHO Writing Group. Nonpharmaceutical interventions for pandemic influenza, national and community measures. Emerg Infect Dis 2006 Jan;12(1):88-94 [Full text]
Yen HL, Monto AS, Webster RG, et al. Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. J Infect Dis 2005 Aug 15;192(4):665-72 [Abstract]